908 Devices Inc.

MASS

US65443P1021

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 16:00:00 2024-05-17 EDT			5-day change	1st Jan Change
6.85 ^USD	-0.44%		+20.18%	-38.95%

04-30	Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024
04-30	Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M	MT

Cam2 Technologies, LLC announced that it has received $45 million in funding from 908 Devices Inc.

April 28, 2024

Cam2 Technologies, LLC announced that it has entered into an equity purchase agreement with new investor, 908 Devices Inc. for a gross proceeds of $45,000,000 on April 29, 2024.

Latest news about 908 Devices Inc.

Transcript : 908 Devices Inc., Q1 2024 Earnings Call, Apr 30, 2024	04-30
Earnings Flash (MASS) 908 DEVICES Posts Q1 Revenue $10M	04-30	MT
908 Devices Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-30	CI
908 Devices Inc. Provides Revenue Guidance for the Full Year 2024	04-30	CI
908 Devices Inc. acquired CAM2 Technologies, LLC for $76.6 million.	04-29	CI
Cam2 Technologies, LLC announced that it has received $45 million in funding from 908 Devices Inc.	04-28	CI
908 Devices Inc. Trace Chemical Identification Technology Adopted by European Agencies	03-12	CI
Transcript : 908 Devices Inc., Q4 2023 Earnings Call, Mar 05, 2024	03-05
908 Devices Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-05	CI
908 Devices Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-05	CI
Earnings Flash (MASS) 908 DEVICES Reports Q4 Revenue $14.4M	03-05	MT
908 Devices Inc. Provides Earnings Guidance for the Full Year 2024	03-05	CI
North American Morning Briefing : S&P 500 Futures -2-	03-05	DJ
908 Devices Stock Falls After CFO Reports Share Sale	01-03	MT
908 Devices Inc. Announces MX908 Integration Capabilities	11-14	CI
908 Devices Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-07	CI
Transcript : 908 Devices Inc., Q3 2023 Earnings Call, Nov 07, 2023	11-07
Earnings Flash (MASS) 908 DEVICES Posts Q3 Revenue $14.3M	11-07	MT
908 Devices Inc. Provides Earnings Guidance for the Full Year 2023	11-07	CI
908 Devices Inc. and Terumo Blood and Cell Technologies Collaborate to Add On-Line Analytics to Quantum Flex Cell Expansion System	11-06	CI
908 Devices Gets $10.4 Million Order From US Defense Forces	23-10-25	MT
908 Devices Inc. Receives $10.4 Million Order from the United States Air Force for Its Handheld MX908 Device	23-10-24	CI
908 Devices Inc. Enters Initial Production Phase of US Department of Defense Aerosol and Vapor Chemical Agent Detector Program	23-09-26	CI
908 Devices Launches Maverick for Real-Time In-Line Monitoring of Multiple Bioprocess Parameters	23-09-18	CI
908 Devices Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-08	CI

908 Devices Inc. offers a suite of purpose-built handheld and desktop mass spectrometry (Mass Spec) devices for the point of need chemical and biochemical analysis. The Company's Mass Spec devices are used at the point of need to interrogate unknown and invisible materials and provide answers to address problems in life sciences research, bioprocessing, industrial biotechnology, forensics and adjacent markets. Its products include MX908, Rebel, ZipChip, Maven and Maverick. MX908 is a handheld, battery-powered, Mass Spec device designed for the analysis of solid, liquid, vapor and aerosol materials of unknown identity. MX908 is a multi-purpose device utilized by a spectrum of user segments for a variety of forensic field applications, including chemical, explosive, priority drug and hazardous materials operations, detecting materials at the trace level. The Rebel is a small desktop analyzer providing real-time information on the extracellular environment in bioprocesses.

Sector

Advanced Medical Equipment & Technology

Calendar

2024-05-29 - Leerink Partners Healthcare Crossroads Conference

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for 908 Devices Inc.

Trading Rating

Investor Rating

ESG Refinitiv

D+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

6.85 USD

Average target price

15.33 USD

Spread / Average Target

+123.84%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
908 DEVICES INC.	-38.95%	236M
SARTORIUS AG	-19.42%	18.12B
QUIDELORTHO CORPORATION	-41.90%	2.87B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+19.36%	1.9B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-1.05%	1.65B
BIOTAGE AB	+33.96%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.83%	957M
CONTEC MEDICAL SYSTEMS CO.,LTD	-21.96%	896M
REVENIO GROUP OYJ	+7.07%	841M
CELLAVISION AB	+10.85%	523M

Medical Diagnostic & Testing Equipment

908 Devices Inc.

Equities

MASS

US65443P1021

Advanced Medical Equipment & Technology

Cam2 Technologies, LLC announced that it has received $45 million in funding from 908 Devices Inc.

Latest news about 908 Devices Inc.

Chart 908 Devices Inc.

Company Profile

Income Statement Evolution

Ratings for 908 Devices Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Diagnostic & Testing Equipment